ZNF433 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.876200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.315600E-01
Normal-vs-Stage2
1.609680E-02
Normal-vs-Stage3
2.219300E-03
Normal-vs-Stage4
6.018300E-02
Stage1-vs-Stage2
1.747190E-01
Stage1-vs-Stage3
7.231800E-02
Stage1-vs-Stage4
3.928200E-01
Stage2-vs-Stage3
1.279920E-02
Stage2-vs-Stage4
5.321400E-01
Stage3-vs-Stage4
3.616100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.192100E-02
Normal-vs-AfricanAmerican
2.755900E-02
Normal-vs-Asian
2.213800E-02
Caucasian-vs-AfricanAmerican
1.423390E-01
Caucasian-vs-Asian
2.116800E-01
AfricanAmerican-vs-Asian
6.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.870400E-02
Normal-vs-Female
3.565800E-02
Male-vs-Female
7.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.596000E-01
Normal-vs-Age(41-60Yrs)
1.073450E-01
Normal-vs-Age(61-80Yrs)
1.355740E-02
Normal-vs-Age(81-100Yrs)
5.829800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.016800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.237610E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.118000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.131200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.724200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.161400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.556100E-02
Normal-vs-Daily Drinker
1.491030E-01
Normal-vs-Weekly Drinker
1.123920E-02
Normal-vs-Occasional Drinker
9.200200E-03
Normal-vs-Social Drinker
1.891620E-01
Non Drinker-vs-Daily Drinker
8.516200E-01
Non Drinker-vs-Weekly Drinker
8.338000E-01
Non Drinker-vs-Occasional Drinker
8.477200E-01
Non Drinker-vs-Social Drinker
4.309400E-01
Daily Drinker-vs-Weekly Drinker
7.188800E-01
Daily Drinker-vs-Occasional Drinker
9.762000E-01
Daily Drinker-vs-Social Drinker
6.286600E-01
Weekly Drinker-vs-Occasional Drinker
6.451000E-01
Weekly Drinker-vs-Social Drinker
3.724200E-01
Occasional Drinker-vs-Social Drinker
5.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.431600E-01
Normal-vs-Grade 2
8.851800E-02
Normal-vs-Grade 3
1.361180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.328250E-01
Grade 1-vs-Grade 3
1.317610E-01
Grade 1-vs-Grade 4
2.431600E-01
Grade 2-vs-Grade 3
8.819800E-01
Grade 2-vs-Grade 4
8.851800E-02
Grade 3-vs-Grade 4
1.361180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.836160E-02
Normal-vs-NonDiabetic
5.281900E-02
Diabetic-vs-NonDiabetic
6.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.563100E-03
Normal-vs-NoPancreatitis
2.206000E-02
Pancreatitis-vs-NoPancreatitis
1.132570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.894200E-02
Normal-vs-N1
2.383600E-02
N0-vs-N1
9.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.852150E-02
Normal-vs-TP53-NonMutant
3.247000E-01
TP53-Mutant-vs-TP53-NonMutant
2.934400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
